https://european-biotechnology.net/wp-content/uploads/2025/10/Hemab_1760407451_tg-e1761576825745.jpg535957Thomas Gabrielczyk/wp-content/uploads/2019/12/ebn-1-300x135.pngThomas Gabrielczyk2025-10-27 14:53:532025-10-27 14:53:53Hemab Therapeutics bags US$157m in Series C financing
https://european-biotechnology.net/wp-content/uploads/2025/10/Electra-CD47_PDB_2JJS-e1761139055624-1030x580-1.png5801030Thomas Gabrielczyk/wp-content/uploads/2019/12/ebn-1-300x135.pngThomas Gabrielczyk2025-10-22 13:23:152025-10-22 13:23:15Electra Therapeutics raises US$183m in Series C financing
https://european-biotechnology.net/wp-content/uploads/2025/10/ESMO-e1761055975736-1030x581-1.jpg5811030Thomas Gabrielczyk/wp-content/uploads/2019/12/ebn-1-300x135.pngThomas Gabrielczyk2025-10-21 14:13:192025-10-21 14:13:19Tubulis presents first clinical data on ADC TUB-040
https://european-biotechnology.net/wp-content/uploads/2025/10/Merck.jpg470840Thomas Gabrielczyk/wp-content/uploads/2019/12/ebn-1-300x135.pngThomas Gabrielczyk2025-10-17 12:57:312025-10-17 12:57:31Merck KGaA reduces US prices for IVF drugs by 84%
https://european-biotechnology.net/wp-content/uploads/2025/10/Adcytherix_Jack_Elands_CEO_tg-scaled-e1760595632424-1030x580-1.jpg5801030Thomas Gabrielczyk/wp-content/uploads/2019/12/ebn-1-300x135.pngThomas Gabrielczyk2025-10-16 09:03:442025-10-16 09:03:44ADC specialist Adcytherix SAS raises €105m in Series A round
https://european-biotechnology.net/wp-content/uploads/2025/10/tubulis_linker_ADC_web.jpg540960Thomas Gabrielczyk/wp-content/uploads/2019/12/ebn-1-300x135.pngThomas Gabrielczyk2025-10-15 09:08:402025-10-15 09:08:40Tubulis secures €308m in record-breaking Series C financing
